Cordlife Group Limited (CLIFF)

Market Cap	28.44M -4.0%
Revenue (ttm)	30.21M +40.5%
Net Income	-9.83M
EPS	-0.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	12,013
Open	0.0689
Previous Close	0.1019
Day's Range	0.0689 - 0.0689
52-Week Range	0.0689 - 0.1722
Beta	0.68
RSI	n/a
Earnings Date	May 25, 2026

About Cordlife Group

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such as newborn genetic and metabolic screenings; pediatric vision and ear screenings; pediatric allergen test; and genetic talent test ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2001
• Employees: 538
• Stock Exchange: OTCMKTS
• Ticker Symbol: CLIFF

Financial Performance

In 2025, Cordlife Group's revenue was 38.85 million, an increase of 40.53% compared to the previous year's 27.65 million. Losses were -12.64 million, -33.06% less than in 2024.

Financial numbers in SGD